XTNTXtant Medical Holdings, Inc.

NYSE xtantmedical.com


$ 0.72 $ -0.03 (-3.38 %)    

Friday, 31-May-2024 15:54:59 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 0.72
$ 0.75
$ 0.00 x 0
$ 0.00 x 0
$ 0.72 - $ 0.75
$ 0.60 - $ 1.45
114,778
na
93.74M
$ 0.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-03-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-21-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-29-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-10-2016 06-30-2016 10-Q
33 05-11-2016 03-31-2016 10-Q
34 03-24-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 03-18-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-xtant-medical-hldgs-raises-price-target-to-3

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target from $2 to $3.

 xtant-medical-hldgs-q1-2024-gaap-eps-003-misses-001-estimate-sales-27873m-beat-25750m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $...

 xtant-medical-holdings-inc-files-for-mixed-shelf-offering-of-up-to-150m

- SEC Filing

 xtant-medical-q4-gaap-eps-003-misses-002-estimate-sales-2811m-beat-2655m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $...

 btig-initiates-coverage-on-xtant-medical-hldgs-with-buy-rating-announces-price-target-of-2

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Targ...

 xtant-medical-hldgs-q3-eps-007-up-from-003-yoy-sales-2502m-beat-1890m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.07 per share. This is a 333.33 percent increase over losses o...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 xtant-medical-announces-acquisition-of-nanoss-production-operations-from-rti-surgical--the-purchase-price-for-the-assets-was-2-million-in-cash-plus-contingent-payments-based-on-future-sales-of-next-generation-nanoss-products

Expands Xtant's Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) --...

 xtant-medical-raises-fy23-revenue-guidance-to-75m-77m-vs-consensus-of-75m-prior-guidance-73m-75m

Xtant Medical Holdings, Inc.'s (AMEX:XTNT) revised guidance range represents annual revenue growth of approximately 29% to ...

 xtant-medical-hldgs-q2-eps-002-inline-sales-2023m-beat-1950m-estimate

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This i...

 earnings-scheduled-for-august-1-2023

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for its first quarter. • BP (NYS...

 craig-hallum-maintains-buy-on-xtant-medical-hldgs-raises-price-target-to-12

Craig-Hallum analyst Chase Knickerbocker maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and raises the price target fr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION